This week we are going to discuss a topic that we had briefly touched on earlier, the neurologic autoimmune conditions: myasthenia gravis and Lambert Eaton Syndrome (LEMS). To review: Myasthenia ...

Conditions that produce symptoms similar to those of myasthenia gravis include cholinergic crisis, which can occur as a ...

Conditions that produce symptoms similar to those of myasthenia gravis include cholinergic crisis, which can occur as a result of toxin exposure or anesthetic overdose, or Lambert-Eaton syndrome, a ...

Exclusion criteria: (1) Neuromuscular junction disorders, including Myasthenia gravis and Lambert-Eaton syndrome, are excluded based on clinical features, neostigmine test, fatigue testing, repetitive ...

The safe administration of anti-CD19 CAR T cells in two women with concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome resulted in profound B cell depletion and normalization of ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

Nicholas J. Silvestri, MD, expects that the upcoming 2025 American Academy of Neurology Annual Meeting in San Diego will be an exciting event for the field of myasthenia gravis (MG), with ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...